QI
GHDX

Quotient Investors’s Genomic Health, Inc. GHDX Stock Holding History

Quotient Investors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-59,700
Closed -$1.83M – 283
2013
Q3 		$1.83M Sell
59,700
-600
-1% -$20.1K 0.48% 69
2013
Q2 		$1.91M Buy
+60,300
New +$1.98M 0.54% 59

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Quotient Investors's GHDX Position: Q4 2013 in Review

Quotient Investors sold out of Genomic Health, Inc. (GHDX) in Q4 2013, closing a stake of 59,700 shares — an estimated $1.83M sold.

Quotient Investors first reported a position in GHDX in Q2 2013 and held it in 2 quarters. The position peaked at $1.91M in Q2 2013. 120 funds tracked by Wall St. Rank hold GHDX as of Q4 2013.

  • Quotient Investors reported no remaining Genomic Health, Inc. position as of Q4 2013 after selling out during the quarter.
  • Quotient Investors sold 59,700 Genomic Health, Inc. shares in Q4 2013, an estimated $1.83M.
  • Quotient Investors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 2 quarters.
  • Quotient Investors's Genomic Health, Inc. position peaked at $1.91M in Q2 2013.
  • 120 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2013.

Based on Quotient Investors's 13F filing for Q4 2013, filed 17 Jan 2014.